News
EMA: Guideline on the clinical investigation of medicinal products for the treatment of urinary incontinence
25.07.2013
This guideline considers pharmacodynamic and clinical data required to support indications, dose regimens and durations of therapy for the treatment of urinary incontinence (UI). It applies to the
...
EC: Revision of EU Commission guidelines on Good manufacturing Practice Medicinal Products - annex 16
25.07.2013
This Annex provides guidance on the certification by a Qualified Person (QP) and on batch release within the European Economic Area (EEA) of medicinal products for human or veterinary use holding
...
GMP: How do I apply for a CEP? An updated guideline of the EDQM provides information
25.07.2013
The EDQM recently published an updated guidance entitled \"Guidance for electronic and paper submissions for certificates of suitability (CEPs) applications\". This document describes in detail
...
FDA: Draft Guidance - Cosmetic Good Manufacturing Practices
18.07.2013
This guidance revises the “Cosmetic Good Manufacturing (GMP) Guidelines/Inspection Checklist” by updating it to set forth current practice, and clarify certain topic areas based on recent
...
GMP: Risk-based Approach to APIs Consignments without Written Confirmation
18.07.2013
The provisions of the directive are intended to ensure that API manufacturers in non-EU countries exporting into the EU are registered with their local authorities and subject to adequate
...
GMP: FDA Safety Communication: New boxed warning for thrombosis related to human immune globulin products.
18.07.2013
The analysis of recent data by the U.S. Food and Drug Administration (FDA) has strengthened the association between the use of intravenous, subcutaneous and intramuscular human immune globulin
...
EMA: Draft concept paper on the need for revision of the note for guidance on manufacture of the finished dosage form
11.07.2013
This concept paper addresses the need to update and revise the CPMP/QWP/486/95 note for guidance on manufacture of the finished dosage form (1). This guideline was originally adopted in September
...
FDA: Draft Guidance - Considerations for the Design of Early - Phase Clinical Trials of Cellular and Gene Therapy Products
11.07.2013
This guidance provides recommendations to assist in designing early-phase clinical trials of CGT products. When this guidance is finalized, we believe it will clarify OCTGT’s current
...
FDA: Guidance for Industry: Heparin for Drug and Medical Device Use: Monitoring Crude Heparin for Quality
11.07.2013
This guidance is intended to alert manufacturers of active pharmaceutical ingredients (APIs), pharmaceutical and medical device manufacturers of finished products, repackers, and others to the
...
EMA: Draft note for guidance on clinical investigation of medicinal products for treatment of asthma
04.07.2013
This document is intended to provide guidance for the clinical evaluation of new medicinal products for the treatment of asthma. ...